Materias dentro de su búsqueda.
Materias dentro de su búsqueda.
Historia
34
Cuentos mexicanos
8
Estudio y enseñanza
7
Política y gobierno
7
Aspectos sociales
6
Condiciones sociales
6
Educación
6
Filosofía
6
Historia y crítica
6
Indígenas de México
6
Literatura mexicana
6
Ciencia
5
Investigaciones
5
Leyes y legislación
5
Música popular
5
Arquitectura
4
Condiciones económicas
4
Derechos humanos
4
Descripciones y viajes
4
Ferrocarriles
4
Política económica
4
Administración
3
Administración pública
3
Aztecas
3
Ciencias sociales
3
Crítica e interpretación
3
Cuentos cubanos
3
Cuentos estadounidenses
3
Derecho constitucional
3
Empresas comunitarias
3
-
69881por Rubinstein, Samuel, Lynch, Ryan C., Desai, Aakash, Stratton, Catherine, Jha, Alokkumar, Bakouny, Ziad, Schmidt, Andrew, Sica, R. Alejandro, Bhutani, Divaya, Shah, Dimpy P., Wall, Sarah A, Lyman, Gary H., Kuderer, Nicole M., Weiss, Matthias, Warner, Jeremy L., Stockerl-Goldstein, Keith E., Mesa, Ruben, Thompson, Michael A.“…Kuderer:Janssen: Consultancy; G1 Therapeutics: Consultancy; Beyond Springs: Consultancy; Spectrum Pharmaceuticals: Consultancy; Bayer: Consultancy; Bristol-Myers Squibb: Consultancy; celldex: Consultancy; Total Health: Consultancy; Invitae: Consultancy. Warner:HemOnc.orgLLC: Other: Shareholder/Stockholder/Stock options; National Cancer Institute: Research Funding; IBM Watson Health: Consultancy; Westat: Consultancy. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
69882por Neparidze, Natalia, Lau, Krystal W., Wang, Xiaoliang, Davidoff, Amy J., Huntington, Scott F., Jamy, Omer Hassan, Calip, Gregory, Shah, Harsh, Stephens, Deborah M., Miksad, Rebecca A., Parikh, Ravi, Takvorian, Samuel, Goyal, Gaurav, Seymour, Erlene K“…Miksad: Flatiron Health Inc: Current Employment, Current holder of individual stocks in a privately-held company; Roche: Current equity holder in publicly-traded company. Parikh: Onc.AI: Current holder of individual stocks in a privately-held company; Humana: Honoraria, Research Funding; Flatiron Health Inc: Honoraria; Thyme Care: Honoraria; Nanology: Honoraria; GNS Healthcare: Current holder of individual stocks in a privately-held company. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
69883por Goyal, Gaurav, Lau, Krystal W., Wang, Xiaoliang, Davidoff, Amy J., Huntington, Scott F., Jamy, Omer Hassan, Calip, Gregory, Shah, Harsh, Stephens, Deborah M., Miksad, Rebecca A., Parikh, Ravi, Takvorian, Samuel, Neparidze, Natalia, Seymour, Erlene K“…Parikh: GNS Healthcare: Current holder of individual stocks in a privately-held company; Onc.AI: Current holder of individual stocks in a privately-held company; Humana: Honoraria, Research Funding; Nanology: Honoraria; Thyme Care: Honoraria; Flatiron Health Inc: Honoraria. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
69884por Wiedmeier, Julia E., Iqbal, Madiha, Munoz, Javier, Bezerra, Evandro D., Garcia Robledo, Juan Esteban, Bansal, Radhika, Johnston, Patrick B., Hathcock, Matthew, Larsen, Jeremy T., Bergsagel, P. Leif, Wang, Yucai, Reeder, Craig B., Leis, Jose F., Fonseca, Rafael, Palmer, Jeanne M., Warsame, Rahma M, Kourelis, Taxiarchis, Hayman, Suzanne R., Dingli, David, Kapoor, Prashant, Kumar, Shaji, Durani, Urshila, Villasboas, Jose C., Paludo, Jonas, Bennani, N. Nora, Ansell, Stephen M., Castro, Januario E, Kharfan-Dabaja, Mohamed A., Lin, Yi, Vergidis, Paschalis, Murthy, Hemant S., Rosenthal, Allison C.“….: Speakers Bureau; Pharmacyclics/Abbvie, Bayer, Gilead/Kite Pharma, Pfizer, Janssen, Juno/Celgene, BMS, Kyowa, Alexion, Beigene, Fosunkite, Innovent, Seattle Genetics, Debiopharm, Karyopharm, Genmab, ADC Therapeutics, Epizyme, Beigene, Servier: Consultancy; Targeted Oncology: Honoraria; OncView: Honoraria; Kyowa: Honoraria. Bergsagel: Oncopeptides: Consultancy, Honoraria; Novartis: Consultancy, Honoraria, Patents & Royalties: human CRBN mouse; Pfizer: Consultancy, Honoraria; Celgene: Consultancy, Honoraria; Janssen: Consultancy, Honoraria; Genetech: Consultancy, Honoraria; GSK: Consultancy, Honoraria. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
69885por Li, Ang, Kuderer, Nicole M., Warner, Jeremy L., Desai, Aakash, Shah, Dimpy P., Fu, Julie, Li, Monica, Zon, Rebecca, Shah, Surbhi, Gulati, Shuchi, Khaki, Ali Raza, Kulkarni, Amit, Elshoury, Amro, Thompson, Michael A., Grivas, Petros, de Lima Lopes, Gilberto, Shyr, Yu, Pennell, Nathan A, Schmidt, Andrew, Friese, Christopher R, Stover, Daniel, Patel, Jaymin, Halmos, Balazs, Choueiri, Toni K., Peters, Solange, Rivera, Donna R., Painter, Corrie, Rini, Brian, Lyman, Gary H., Connors, Jean M., Rosovsky, Rachel P.“…[Figure: see text] DISCLOSURES: Kuderer:G1 Therapeutics: Consultancy; Total Health: Consultancy; Invitae: Consultancy; Beyond Springs: Consultancy; Bristol-Myers Squibb: Consultancy; celldex: Consultancy; Bayer: Consultancy; Spectrum Pharmaceuticals: Consultancy; Janssen: Consultancy. Warner:HemOnc.orgLLC: Other: Shareholder/Stockholder/Stock options; IBM Watson Health: Consultancy; Westat: Consultancy; National Cancer Institute: Research Funding. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
69886por Garcia-Manero, Guillermo, McCloskey, James K, Griffiths, Elizabeth A., Yee, Karen, Zeidan, Amer M., Al-Kali, Aref, Deeg, H. Joachim, Patel, Prapti, Sabloff, Mitchell, Keating, Mary-Margaret, Dao, Kim-Hien, Zhu, Nancy, Gabrail, Nashat Y., Fazal, Salman, Maly, Joseph, Odenike, Olatoyosi, Kantarjian, Hagop, DeZern, Amy E., O'Connell, Casey L., Roboz, Gail J., Busque, Lambert, Wells, Richard A., Amin, Harshad, Randhawa, Jasleen K., Leber, Brian, Hao, Yong, Keer, Harold N., Azab, Mohammad, Savona, Michael R.“…MDS Symp. 2021 Garcia-Manero, et al, Phase III, Randomized, Placebo-Controlled Trial of CC-486 (Oral Azacitidine) in Patients with Lower-Risk Myelodysplastic Syndromes. J.Clin.Onc. 2021 39:13, 1426-1436 [Figure: see text] DISCLOSURES: McCloskey: Pfizer: Consultancy; Jazz: Consultancy, Speakers Bureau; COTA: Other: Equity Ownership; Incyte: Speakers Bureau; Takeda: Consultancy, Speakers Bureau; Novartis: Consultancy; BMS: Honoraria, Speakers Bureau; Amgen: Speakers Bureau. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Online Artículo Texto